Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
By mimicking the function of the GIP and GLP-1 hormones and boasting improved pharmacokinetics, tirzepatide effectively: Increases insulin production Improves blood sugar management (in T2D) Suppresses appetite Induces weight loss These benefits have all been demonstrated in phase-3 studies, which has led to tirzepatide's approval by the FDA for T2D treatment
Still less expensive than most
4,26 Additionally, GLP-1, through the insulin secretion it induces, also promotes glycogen synthesis and inhibits gluconeogenesis in the liver, and also increases fat storage in adipocytes
The compound was originally designated LY3437943 during early development phases before receiving its current name
Shown where already published on the recipe.
US$ 24.89
US$ 23.30
US$ 29.35
